Hemoglobin A1c Testing Markets 2016 - Hemoglobin A1c Testing is now an Essential Assay in the Diabetes Testing Repertoire

Dublin, Jan. 13, 2016 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/5mpv9n/hemoglobin_a1c) has announced the addition of the "Hemoglobin A1c Testing Markets" report to their offering.

Hemoglobin A1c (HbA1c) testing is the most recent major technology to have entered the diabetes testing market. As the global prevalence of diabetes mellitus continues to increase rapidly, with more than 366 million diabetics worldwide, hemoglobin A1c testing is now an essential assay in the diabetes testing repertoire. Its clinical utility and improvements in its accuracy and implementation of standardized protocols have translated into continued market growth. This report describes the specific market segment that encompasses hemoglobin A1c testing for diagnosing and monitoring diabetes.

The study reviews all of the generally accepted clinical analytical methods that are currently in use today for measuring HbA1c levels. Moreover, it examines clinical measurement devices and reagents as utilized in hospitals, clinics, doctor's offices and at-home care locations. The report also analyzes almost all of the companies known to be marketing, manufacturing or developing hemoglobin A1c testing. Detailed tables and charts with sales forecasts and market-share data are also included.

Companies Mentioned

• Abbott Laboratories
• A. Menarini Diagnostics
• Alere, Inc.
• ARKRAY USA, Inc.
• Axis-Shield Plc
• Bayer Healthcare Diagnostics
• Beckman Coulter, Inc
• Bio-Rad Laboratories, Inc.
• EKF Diagnostics
• Infopia Co., Ltd.
• Ortho Clinical Diagnostics (part of Johnson & Johnson)
• Quotient Diagnostics
• Randox Laboratories
• Roche Diagnostics
• Siemens AG
• Tosoh Bioscience, Inc.
• Trinity Biotech Plc

Key Topics Covered:

1. Overview

2. Diabetes

3. Market Analysis: Size, Growth, Share and Competitors

4. Overview of HbA1c Testing

5. HbA1c Testing Devices on the Market

6. Business Trends in HbA1c Testing

7. Regulatory Environment and Insurance Reimbursements

8. Company Profiles

For more information visit http://www.researchandmarkets.com/research/5mpv9n/hemoglobin_a1c

CONTACT: Research and Markets
         Laura Wood, Senior Manager
         [email protected]

         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900

         U.S. Fax: 646-607-1907
         Fax (outside U.S.): +353-1-481-1716

         Sector: Pharmaceuticals, Coagulation and Hemostasis Testing